TriReme Medical Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 106
Employees
  • Latest Deal Type
  • Merger of Eq.

TriReme Medical General Information

Description

Developer, manufacturer and distributor of advanced therapeutic technology systems designed for the treatment of complex vascular disease. The company develops next generation percutaneous devices for the treatment of coronary and peripheral vascular disease. Its novel balloon and stent therapies are specifically designed for the large, unmet clinical needs in the complex coronary and peripheral artery disease markets, providing physicians with new and differentiated devices to improve outcomes in complex peripheral and coronary interventions.

Contact Information

Website
www.trirememedical.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Acquirer
QT Vascular
Primary Office
  • 7060 Koll Center Parkway
  • Suite 300
  • Pleasanton, CA 94566
  • United States
+1 (925) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TriReme Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger of Equals 11-Jul-2013 000.00 Completed Generating Revenue
6. Later Stage VC 28-Nov-2012 0000 000.00 Completed Generating Revenue
5. Later Stage VC (Series D) 12-Oct-2010 0000 000.00 000.00 Completed Startup
4. Early Stage VC 10-Nov-2009 00.000 000.00 Completed Startup
3. Early Stage VC 16-Oct-2007 000.00 000.00 000.00 Completed Startup
2. Early Stage VC (Series B) 27-Apr-2006 $3.44M $5.36M 000.00 Completed Startup
1. Early Stage VC (Series A) 11-Nov-2005 $1.92M $1.92M 000.00 Completed Startup
To view TriReme Medical’s complete valuation and funding history, request access »

TriReme Medical Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 2,264,157 $0.001000 $0.12 $1.52 $1.52 1x $1.52 3.2%
Series A 2,271,276 $0.001000 $0.08 $1 $1 1x $1 3.21%
To view TriReme Medical’s complete cap table history, request access »

TriReme Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer, manufacturer and distributor of advanced therapeutic technology systems designed for the treatment of complex
Surgical Devices
Pleasanton, CA
106 As of 2016
000.00
00000000000 000.00

00000 00

equat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
00000000 0000000
Aliso Viejo, CA
0 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00

0000000

nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor
00000000 0000000
Didcot, United Kingdom
000 As of 0000
00000
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TriReme Medical Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Okami Medical Venture Capital-Backed Aliso Viejo, CA 0 000.00 00000000000 000.00
0000000 0000000 Formerly PE-Backed Didcot, United Kingdom 000 00000 000000&0
00000000 0000000 Venture Capital-Backed Pembroke Pines, FL 00 00000 00000000000 00000
0000000000000 Corporation New York, NY 000 000.00 000000 - 000 000.00
000000000 0000000 Formerly VC-backed Exton, PA 00 000.00 000000&0 000.00
You’re viewing 5 of 11 competitors. Get the full list »

TriReme Medical Executive Team (9)

Name Title Board Seat Contact Info
Randal Farwell Chief Financial Officer
Maria Pizarro Executive Vice President and Vice President, Research & Development
Eitan Konstantino Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Christopher Haig Vice President of Marketing, Sales and Business Development
You’re viewing 4 of 9 executive team members. Get the full list »

TriReme Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TriReme Medical Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Adams Street Partners Fund of Funds Minority 000 0000 000000 0
Bio*One Capital Corporate Venture Capital Minority 000 0000 000000 0
Luminor Capital PE/Buyout Minority 000 0000 000000 0
Three Arch Partners Venture Capital Minority 000 0000 000000 0
Yellowstone Capital Partners PE/Buyout Minority 000 0000 000000 0
To view TriReme Medical’s complete investors history, request access »

Ready to get started?

Request a free trial